We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+19.52%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$8B
AUM Growth
+$718M
Cap. Flow
-$112M
Cap. Flow %
-1.4%
Top 10 Hldgs %
32.48%
Holding
287
New
37
Increased
60
Reduced
158
Closed
30

Top Buys

Rank Stock Value
1
FWRG icon
First Watch Restaurant Group
FWRG
+$56.6M
2
TKO icon
TKO Group
TKO
+$47.8M
3
PLTR icon
Palantir
PLTR
+$43.5M
4
APPF icon
AppFolio
APPF
+$31.9M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$31.6M

Top Sells

Rank Stock Value
1
EDR
Endeavor Group Holdings, Inc.
EDR
+$53.1M
2
DE icon
Deere & Co
DE
+$49.8M
3
NVDA icon
NVIDIA
NVDA
+$38.2M
4
CALX icon
Calix
CALX
+$33.1M
5
SNOW icon
Snowflake
SNOW
+$31.8M

Sector Composition

Rank Sector Weight
1 Technology 33.99%
2 Consumer Discretionary 18.65%
3 Healthcare 16.16%
4 Communication Services 12.62%
5 Industrials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODD icon
226
ODDITY Tech
ODD
$828M
$731K 0.01%
16,830
-1,134
-6% -$48.9K
PM icon
227
Philip Morris
PM
$303B
$682K 0.01%
+7,440
New +$686K
ECHO
228
EchoStar
ECHO
$26.8B
$678K 0.01%
+47,563
New +$663K
GRND icon
229
Grindr
GRND
$2.67B
$674K 0.01%
66,544
+627
+1% +$5.58K
RNLX
230
DELISTED
Renalytix plc American Depositary Shares
RNLX
$655K 0.01%
761,108
-118,343
-13% -$81K
XENE icon
231
Xenon Pharmaceuticals
XENE
$5.45B
$650K 0.01%
+15,092
New +$694K
SILK
232
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$640K 0.01%
34,932
+14,946
+75% +$237K
CMPS
233
Compass Pathways
CMPS
$1.91B
$631K 0.01%
75,795
+45,536
+150% +$459K
FULC icon
234
Fulcrum Therapeutics
FULC
$288M
$619K 0.01%
+65,600
New +$586K
ETN icon
235
Eaton
ETN
$152B
$603K 0.01%
1,928
+247
+15% +$67.5K
DKNG icon
236
DraftKings
DKNG
$12.2B
$583K 0.01%
12,832
+521
+4% +$21.2K
NAMS icon
237
NewAmsterdam Pharma
NAMS
$2.53B
$579K 0.01%
+24,466
New +$497K
SNAP icon
238
Snap
SNAP
$9.86B
$572K 0.01%
49,836
-118
-0.2% -$1.58K
PATH icon
239
UiPath
PATH
$7.42B
$564K 0.01%
24,890
-9,354
-27% -$219K
SHIM icon
240
Shimmick
SHIM
$138M
$547K 0.01%
95,051
-76,874
-45% -$490K
BCYC
241
Bicycle Therapeutics
BCYC
$257M
$530K 0.01%
+21,268
New +$452K
RCKT icon
242
Rocket Pharmaceuticals
RCKT
$374M
$519K 0.01%
19,270
-109
-0.6% -$3.1K
ENFN
243
DELISTED
Enfusion, Inc.
ENFN
$508K 0.01%
54,919
+12,342
+29% +$109K
JANX icon
244
Janux Therapeutics
JANX
$1.01B
$436K 0.01%
+11,591
New +$252K
VRT icon
245
Vertiv
VRT
$90.3B
$394K ﹤0.01%
+4,819
New +$303K
UDMY
246
DELISTED
Udemy
UDMY
$373K ﹤0.01%
33,995
+16,589
+95% +$206K
APP icon
247
Applovin
APP
$111B
$350K ﹤0.01%
+5,063
New +$268K
ETSY icon
248
Etsy
ETSY
$6.79B
$340K ﹤0.01%
4,952
-43
-0.9% -$3.09K
EWCZ
249
DELISTED
European Wax Center
EWCZ
$315K ﹤0.01%
24,244
-52,484
-68% -$751K
TDW icon
250
Tidewater
TDW
$4.57B
$306K ﹤0.01%
3,328
+62
+2% +$4.62K
8 9
10
11 12

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Gilder Gagnon Howe & Co held 287 positions worth $8B, up 9.8% from $7.29B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co's Q1 2024 filing shows 37 new, 60 increased, 158 reduced and 30 closed positions. Its largest new stake was TKO Group: 574,544 shares worth $49.6M. The largest sale was Endeavor Group Holdings, Inc., an estimated $53.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q1 2024 buy was TKO Group: 574,544 shares worth $49.6M.
  • Gilder Gagnon Howe & Co added most to First Watch Restaurant Group in Q1 2024, an estimated $56.6M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $38.2M.
  • Gilder Gagnon Howe & Co fully exited Endeavor Group Holdings, Inc. in Q1 2024, selling an estimated $53.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $8B portfolio in Q1 2024.
  • Gilder Gagnon Howe & Co opened 37 new positions and closed 30 in Q1 2024.
  • Gilder Gagnon Howe & Co's portfolio value rose 9.8% quarter-over-quarter to $8B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2024, filed 15 May 2024.